For Immediate Release:
April 13, 2021
Los Angeles County Pauses Use of Johnson & Johnson Vaccine Following FDA and CDC Recommendation
Out of an abundance of caution, Los Angeles County is following the recommendation of the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) to pause the use of Johnson & Johnson vaccine after reports that six women between the ages of 18 and 48 developed unusual types of blood clots 6 to 13 days after receiving the vaccine. This pause will last until the FDA and CDC complete their review, which is expected to take several days. Vaccine providers in Los Angeles County will contact patients about rescheduling or providing a new appointment for Pfizer or Moderna vaccine.
These reactions are extremely rare, as nearly 7,000,000 people have received the Johnson & Johnson vaccine in the United States to date. People who received the vaccine in the last 3 weeks should look for any symptoms of these unusual clots, including severe headaches, abdominal or leg pain, and shortness of breath, and contact their medical provider if symptoms develop. People who don't have a medical provider can call 2-1-1 to connect with a healthcare provider.
We are grateful to the researchers and scientists working to ensure that all medications or vaccines, including the COVID-19 vaccines, have the highest safety standards.
The Department of Public Health is committed to promoting health equity and ensuring optimal health and well-being for all 10 million residents of Los Angeles County. Through a variety of programs, community partnerships and services, Public Health oversees environmental health, disease control, and community and family health. Nationally accredited by the Public Health Accreditation Board, the Los Angeles County Department of Public Health comprises nearly 4,500 employees and has an annual budget of $1.2 billion.
#####
